|
A more recent version of this article appeared on September 1, 2003
Papers In Press, published online ahead of print July 1, 2003
J. Lipid Res., doi:10.1194/jlr.M300248-JLR200
Submitted on June 10, 2003
Revised on July 1, 2003
Accepted on June 16, 2003
Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase
Lluis Fajas, Stéphanie Miard, Michael R. Briggs, and Johan Auwerx
IGBMC, Strasbourg 67404
Corresponding Author: fajas{at}montp.inserm.fr
Selective cyclo-oxygenase-2 (COX-2) inhibitors are non-steroidal anti-inflammatory drugs (NSAID) used in the management of inflammatory diseases. We demonstrate here that inhibition of the COX-2 enzyme impairs adipocyte differentiation. The inhibition of adipogenesis occurs in the early clonal expansion phase. In particular, COX-2 inhibition limits cell cycle re-entry required before terminal adipocyte differentiation. This inhibition of adipogenesis is independent of the production of the PPARg ligand PGJ2, but dependent on the production of proliferative prostaglandins, such as PGE2. Modulation of the activity of COX-2 enzyme, via COX-2 selective inhibitors, might open up new perspectives in the control of obesity and related metabolic diseases.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Sen, M. Styner, Z. Xie, N. Case, C. T. Rubin, and J. Rubin
Mechanical Loading Regulates NFATc1 and {beta}-Catenin Signaling through a GSK3{beta} Control Node
J. Biol. Chem.,
December 11, 2009;
284(50):
34607 - 34617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Duncan, E. Sarkadi-Nagy, K. Jaworski, M. Ahmadian, and H. S. Sul
Identification and Functional Characterization of Adipose-specific Phospholipase A2 (AdPLA)
J. Biol. Chem.,
September 12, 2008;
283(37):
25428 - 25436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tzameli, H. Fang, M. Ollero, H. Shi, J. K. Hamm, P. Kievit, A. N. Hollenberg, and J. S. Flier
Regulated Production of a Peroxisome Proliferator-activated Receptor-{gamma} Ligand during an Early Phase of Adipocyte Differentiation in 3T3-L1 Adipocytes
J. Biol. Chem.,
August 20, 2004;
279(34):
36093 - 36102.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|